IAQ.net Resources

Safe Air - Long Term Playbook -Erlab Inc.

Issue link: https://hi.iaq.net/i/1368103

Contents of this Issue

Navigation

Page 13 of 15

14 Real-world performance results: In order to further validate the Halo's efficiency at mitigating the risk of airborne viral transmission, we tested the Halo within an isolation room of a confirmed COVID 19 positive patient against an adjacent isolation room of a confirmed COVID 19 patient of which both shared the same air handling system. Each room was swabbed at the floor, window surface and at the return registers for SARS-CoV-2 using the gold standard of a polymerase chain reaction (PCR) test. The results as (seen below) provide us with some key pieces of information, such as; Viral shedding of each patient and reduction of present SRA-CoV-2 RNA. Based on these results it is clear the patient in room 120 (with the Halo) had significant viral shedding as they were at the beginning of isolation, whereas the patient in room 118 (without HALO) viral shedding was minimal as they were at the end of isolation. However, even with the significant amount of shedding from patients in room 120, there was still no detectable RNA found at the return register, or within the airstream further solidifying the performance of the Halo at mitigating airborne viral loads and concentrations. Antithetical to these results are the results in room 118, where SARS-CoV-02 RNA was present at the return register and within the airstream even without detectable RNA present anywhere else within the room. Contact Us Contact us for more information or report details

Articles in this issue

Links on this page

Archives of this issue

view archives of IAQ.net Resources - Safe Air - Long Term Playbook -Erlab Inc.